Alessandro Fantin Selected Research

Phospholipases (Phospholipase)

1/2016

A Small Molecule Inhibitor of PDK1/PLCγ1 Interaction Blocks Breast and Melanoma Cancer Cell Invasion.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alessandro Fantin Research Topics

Disease

7	Neoplasms (Cancer) 01/2021 - 08/2010
4	Pathologic Neovascularization 01/2016 - 02/2014
3	Eye Diseases (Eye Disease) 01/2016 - 10/2011
2	Edema (Dropsy) 01/2021 - 01/2018
2	Hypoxia (Hypoxemia) 01/2016 - 10/2011
1	Pathologic Processes 01/2021
1	Delayed Puberty 01/2018
1	Neoplasm Metastasis (Metastasis) 01/2016
1	Choroidal Neovascularization 01/2016
1	Kallmann Syndrome (Kallmann's Syndrome) 06/2015
1	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2015
1	Macular Degeneration (Age-Related Maculopathy) 01/2015
1	Retinal Vein Occlusion 10/2011

Drug/Important Bio-Agent (IBA)

4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016 - 02/2014
2	Semaphorins (Semaphorin)IBA 01/2021 - 06/2015
2	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2018 - 06/2015
2	Neuropilin-1IBA 01/2016 - 02/2014
2	Imatinib Mesylate (Gleevec)FDA Link 01/2015 - 06/2014
1	ChromatinIBA 01/2021
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2018
1	CytokinesIBA 01/2018
1	Oxygen (Dioxygen)IBA 01/2016
1	AcidsIBA 01/2016
1	Epidermal Growth Factor (EGF)IBA 01/2016
1	2-O-benzylinositol 1,3,4,5,6-pentakisphosphateIBA 01/2016
1	Phospholipases (Phospholipase)IBA 01/2016
1	Protein Isoforms (Isoforms)IBA 01/2016
1	Semaphorin-3AIBA 01/2016
1	Complement System Proteins (Complement)IBA 06/2014
1	bcr-abl Fusion ProteinsIBA 06/2014
1	Retinaldehyde (Retinal)IBA 10/2011
1	Membrane Proteins (Integral Membrane Proteins)IBA 08/2010

Therapy/Procedure

4	Therapeutics 01/2021 - 06/2014